North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 10 of 10
Details
LDL
Link Added : MHRA Drug Safety Update (Jan 2018): Recombinant human erythropoietins: very rare risk of severe cutaneous adverse reactions (SCARs) : https://www.gov.uk/drug-safety-update/recombinant-human-erythropoietins-very-rare-risk-of-severe-cutaneous-a
12/07/2023 09:02:34
(ebeavers )
UPD
sitematrix Changed from 0 to
03/05/2023 09:10:50
(rpaylor )
UPD
trafficCode Changed from AM to RD
03/05/2023 09:10:50
(rpaylor )
UPD
FurtherInformation Changed from
Prefilled syringes (various strengths)
Approved for management of cancer treatment-induced anaemia in
women receiving platinum-based chemotherapy for ovarian cancer
No longer regularly us
03/05/2023 09:10:50
(rpaylor )
UPD
Epoetin alfa (Eprex
®
) updated to red
03/05/2023 09:10:50
(rpaylor )
LDL
Link Added : Shared Care Guidelines for the Monitoring of Erythropoietins in the Treatment of Patients with Chronic Kidney Disease (CKD) : http://www.northoftyneapc.nhs.uk/wp-content/uploads/sites/6/2023/01/Erythropoietin-for-CKD-SCG-January-2023.pdf
14/02/2023 14:03:49
(DavidS )
UPD
Epoetin alfa (Eprex
®
) b
01/02/2017 14:06:50
(WhitehallJ )
UPD
Epoetin alfa (Eprex
®
) b
23/01/2017 15:01:22
(DavidS )
UPD
Epoetin alfa (Eprex
®
) build
23/01/2017 15:01:11
(DavidS )
UPD
Epoetin alfa (Eprex
®
) Build
29/11/2016 10:37:52
(ClarkH )